Harris Rotman Centessa Pharmaceuticals PLC (CNTA) insider trading activity

CNTA Quotes by TradingView

Harris Rotman is SVP Regulatory Affairs of Centessa Pharmaceuticals plc. Currently has a direct ownership of 62,625 shares of CNTA, which is worth approximately $941,880. The most recent transaction as insider was on Feb 01, 2024, when has been sold 4,267 shares (Ordinary Shares) at a price of $8.1 per share, resulting in proceeds of $34,562. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.6K
0% 3M change
86.94% 12M change
Total Value Held $941,880

Harris Rotman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2024
SELL
Open market or private sale
$34,562 $8.1 p/Share
4,267 Reduced 6.38%
62,625 Ordinary Shares
Feb 01 2024
SELL
Payment of exercise price or tax liability
$33,644 $8.19 p/Share
4,108 Reduced 5.79%
66,892 Ordinary Shares
Feb 01 2024
BUY
Grant, award, or other acquisition
-
37,500 Added 34.56%
71,000 Ordinary Shares
Sep 20 2023
SELL
Open market or private sale
$235,774 $6.29 p/Share
37,484 Reduced 52.81%
33,500 Ordinary Shares
Sep 20 2023
BUY
Exercise of conversion of derivative security
$155,933 $4.16 p/Share
37,484 Added 34.56%
70,984 Ordinary Shares
HR

Harris Rotman

SVP Regulatory Affairs
Cheshire, X0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CNTA